Puyod, Generoso A.
HRN: 15-27-04 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/14/2023
03/20/2023
IV
1.5 G
Q6hr
Cap -MR, Lacerated Wound
Waiting Final Action
Indication: Empirical Escalation Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes